These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8992089)

  • 1. [Clinical study of the effectiveness of a dexpanthenol containing artificial tears solution (Siccaprotect) in treatment of dry eyes].
    Göbbels M; Gross D
    Klin Monbl Augenheilkd; 1996; 209(2-3):84-8. PubMed ID: 8992089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
    Burgess PI; Koay P; Clark P
    Cornea; 2008 May; 27(4):391-4. PubMed ID: 18434839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T
    Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC; Choi JS; Joo CK
    Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
    Lee S; Dausch S; Maierhofer G; Dausch D
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM; McGwin G; Liu B; Owsley C; Rosenstiel C
    Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.
    Kojima T; Ishida R; Dogru M; Goto E; Matsumoto Y; Kaido M; Tsubota K
    Am J Ophthalmol; 2005 Feb; 139(2):242-6. PubMed ID: 15733983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
    Liu Z; Pflugfelder SC
    Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA; Goto E; Tseng SC
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of dry eye disorders].
    Heiligenhaus A; Koch JM; Kemper D; Kruse FE; Waubke TN
    Klin Monbl Augenheilkd; 1994 Mar; 204(3):162-8. PubMed ID: 8196302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.
    Troiano P; Monaco G
    Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast sensitivity and tear layer aberrometry in dry eye patients.
    Ridder WH; LaMotte J; Hall JQ; Sinn R; Nguyen AL; Abufarie L
    Optom Vis Sci; 2009 Sep; 86(9):E1059-68. PubMed ID: 19648840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board.
    Nakamura S; Shibuya M; Nakashima H; Imagawa T; Uehara M; Tsubota K
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2379-87. PubMed ID: 15980225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
    Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.